Medication info

Gliphin Tablets 4 mg (Glymepiride)

Prescription medicationTabletOralExpired
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
Taegeuk Pharmaceutical Co., Ltd.
Appearance
Light blue rectangular tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201906957 · Approved 2019.09.30

This product's status changed to Expired on 2024.09.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering agent to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medicine, it is recommended to follow the instructions under Initial dose. That is, initiate treatment at 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previously administered medicine. 4) Treatment adjustment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur after initial successful management when a sulfonylurea is administered. Therefore, monitor patients carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Taegeuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be administered alone, or for sufficient blood sugar control not achieved with oral hypoglycemic agents, it may be combined with insulin. Additionally, if control is difficult with sulfonylureas or metformin monotherapy, it may be used in combination with metformin. This helps to effectively improve blood sugar when used with various treatment methods.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering agent to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medicine, it is recommended to follow the instructions under Initial dose. That is, initiate treatment at 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previously administered medicine. 4) Treatment adjustment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur after initial successful management when a sulfonylurea is administered. Therefore, monitor patients carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes mellitus or in those with diabetic ketoacidosis or in a comatose state. Patients with a history of allergic reactions to this medication or any of its ingredients should not take it. There is no experience of using this medication in patients with severe liver or very poor kidney function; in such cases, insulin therapy is recommended. Women who are pregnant or may become pregnant, and women who are breastfeeding should not take this medication. Patients with severe infections, before and after surgery, or those who have suffered severe trauma should be treated with insulin instead of this medication. Caution is needed if gastrointestinal disturbances such as diarrhea or vomiting occur, as the absorption of food may be impaired and the risk of hypoglycemia may increase. This medication contains lactose, so patients with lactose intolerance or specific genetic metabolic disorders should not take it. During the first week of dosing, there is an increased risk of hypoglycemia, so blood sugar should be monitored very carefully. Groups at higher risk for low blood sugar include the elderly, individuals in poor nutritional states or those with irregular eating habits, patients with thyroid or adrenal function abnormalities, patients with decreased kidney or liver function, and those taking other medications concurrently. Symptoms of hypoglycemia include headache, severe hunger, dizziness, confusion, drowsiness, and decreased consciousness, so if these symptoms occur, sugar should be consumed immediately or medical personnel should be informed. While taking this medication, maintaining regular meals, exercise, and weight management is very important, and blood sugar control status should be consistently monitored. If hypoglycemia occurs, immediately consume sugar or a sugar-containing beverage to alleviate symptoms, so it is advisable to always have sugar on hand. Taking this medication with other drugs may influence blood sugar control, so inform your doctor or pharmacist of all medications being taken. In cases of overdose, severe hypoglycemia may occur, so immediate emergency treatment is needed, and blood sugar should be continuously monitored. This medication should be kept out of reach of children for safety, and it is important to store it properly sealed in the original container.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disorders
  • anxiety
  • aggression
Show 67 more
  • decreased concentration
  • decreased agility or motivation
  • depression
  • confusion
  • language abnormalities
  • aphasia
  • visual impairment
  • tremors
  • partial paralysis
  • sensory disturbances
  • dizziness
  • weakness
  • loss of self-control
  • temporary mental confusion
  • seizures
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • blurred vision
  • fullness in the upper abdomen
  • pressure sensation
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorder
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • agranulocytosis
  • pancytopenia
  • itching
  • urticaria
  • rash
  • shortness of breath
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • photosensitivity reactions of the skin
  • decreased serum sodium concentration
  • taste disorders
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • joint pain
  • dyspepsia
  • facial swelling
  • erectile dysfunction
  • flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from exposure to air and moisture. It is best to store it at room temperature, between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light blue rectangular tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.